Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Estrogen Receptor Positive Breast Cancer × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Solid Tumor 2 Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Recurrence 1 Non-small Cell Lung Cancer Metastatic 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

vistusertib 1 Fulvestrant 1 Everolimus 1 Estrogens 1 Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02216786 2024-12-02

MANTA

Queen Mary University of London

Phase 2 Completed

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡